Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ALNYLAM PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 677,519 shares of ALNY (ALNYLAM PHARMACEUTICALS INC), worth $224.2M as of 2026-Q1. The position was increased (+3.9% shares). ALNY represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$224.2M
Current Shares
677,519
Total Value Change
+$21.2M
Total Shares Change
-157,894
Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 677,519 |
+3.9% |
| $224.2M |
| 0.0% |
| $318.65 |
32 |
| 2025-Q4 | Decreased | 652,366 | -7.9% | $259.4M | 0.1% | $397.25 | 0 |
| 2025-Q3 | Decreased | 708,564 | -26.1% | $323.1M | 0.1% | $447.49 | 0 |
| 2025-Q2 | Increased | 958,336 | +30.2% | $312.5M | 0.1% | $322.83 | 39 |
| 2025-Q1 | Increased | 736,111 | +3.6% | $198.8M | 0.1% | $268.46 | 32 |
| 2024-Q4 | Increased | 710,598 | +0.6% | $167.2M | 0.0% | $236.01 | 30 |
| 2024-Q3 | Decreased | 706,231 | -15.5% | $194.2M | 0.0% | $274.91 | 0 |
| 2024-Q2 | Increased | 835,413 | +10.1% | $203M | 0.1% | $243.00 | 34 |